Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01272063 · ClinicalTrials.gov registry record

Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography

A clinical trial, sponsored by Carl Zeiss Meditec.

Completed
Registry status
91
Enrollment target

NCT01272063 is a clinical trial that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 91 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01272063 has completed, sponsored by Carl Zeiss Meditec.

COMPLETED
Registry status
91 participants
Enrollment target

Study Summary

The objective of this study is to compare the areas designated as elevated retinal pigment epithelium (RPE) by the Cirrus HD-OCT versus those designated as drusen on color fundus photographs (CFPs).

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2010-11
Est. Completion 2011-02

Sponsor

Carl Zeiss Meditec

18 total trials

What the Registry Record Tells You About NCT01272063

The ClinicalTrials.gov registry entry for NCT01272063 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01272063 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01272063 about?

NCT01272063 is a clinical study titled "Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography". The objective of this study is to compare the areas designated as elevated retinal pigment epithelium (RPE) by the Cirrus HD-OCT versus those designated as drusen on color fundus photographs (CFPs).

What is the current status of trial NCT01272063?

This trial is currently completed. The enrollment target is 91 participants. The study started on 2010-11. Estimated completion is 2011-02.

Who is sponsoring clinical trial NCT01272063?

This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.